Take Control of Your B-CLL Journey with Advanced MRD Monitoring
Living with B-cell Chronic Lymphocytic Leukemia (B-CLL) can feel overwhelming, but you don’t have to navigate this journey alone. Our Minimal Residual Disease (MRD) Monitoring test provides the clarity and confidence you need to make informed decisions about your treatment and future health.
Understanding MRD Monitoring: Your Window into Treatment Effectiveness
Minimal Residual Disease refers to the small number of cancer cells that may remain in your body after treatment. These cells are often undetectable through standard tests but can potentially lead to disease recurrence. Our MRD monitoring uses advanced flow cytometry technology to detect even one cancer cell among 10,000 normal cells, giving you and your doctor unprecedented insight into your treatment’s success.
Think of MRD monitoring as your early warning system – it helps identify potential issues long before they become visible through symptoms or conventional testing methods.
Who Should Consider MRD Monitoring?
This test is particularly important for South Africans with B-CLL who are:
- Currently undergoing or recently completed chemotherapy treatment
- Experiencing changes in treatment response
- Concerned about potential disease recurrence
- Working with their hematologist or oncologist to optimize treatment plans
- Seeking peace of mind about their treatment progress
If you’re feeling uncertain about your treatment’s effectiveness or worried about what the future holds, MRD monitoring can provide the answers you need.
Why MRD Monitoring Matters for Your Health Journey
Early detection through MRD monitoring offers significant benefits for B-CLL patients across South Africa:
- Peace of Mind: Know exactly where you stand in your treatment journey
- Treatment Optimization: Help your doctor make informed decisions about continuing, changing, or stopping treatment
- Early Intervention: Detect potential issues before they become serious problems
- Reduced Anxiety: Replace uncertainty with clear, actionable information
- Personalized Care: Receive treatment plans tailored to your specific response
Understanding Your Results: Clear Guidance Every Step
We understand that waiting for test results can be stressful. That’s why we provide:
- Clear Interpretation: Easy-to-understand results with expert analysis
- Quick Turnaround: Results within 3 working days from sample receipt
- Professional Support: Our team is available to answer your questions
- Comprehensive Reporting: Detailed findings that your doctor can use immediately
Your results will clearly indicate whether MRD is detected and at what level, helping you and your healthcare team make the best decisions for your ongoing care.
Affordable, Accessible Care for South Africans
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| MRD Monitoring for B-CLL | ZAR 8,350 | ZAR 5,700 | ZAR 2,650 |
Turnaround Time: Sample accepted daily by 11 am; Report available in 3 working days
Sample Requirements: Bone marrow and blood samples collected in specific tubes with mandatory clinical information
Why Trust Oracle Genomics for Your MRD Monitoring?
We’re committed to providing South Africans with the highest quality healthcare services:
- Nationwide Coverage: Convenient testing available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Analysis: Specialized hematologists and oncologists oversee every test
- Advanced Technology: State-of-the-art flow cytometry for unparalleled accuracy
- Patient-Focused Care: We understand the emotional journey of living with B-CLL
- Reliable Results: Trusted by healthcare professionals throughout South Africa
Take the Next Step in Your Health Journey Today
Don’t let uncertainty about your treatment progress create unnecessary stress. Our MRD monitoring test provides the clarity and confidence you need to move forward with your B-CLL management.
Limited Time Offer: Save ZAR 2,650 on this essential monitoring test. Early detection could make all the difference in your treatment journey.
Available throughout South Africa including major centres in Johannesburg, Cape Town, Durban and Pretoria.
